AIA
VRTX icon

AIMZ Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

AIMZ Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.9M Sell
19,931
-25
-0.1% -$11.1K 2.72% 7
2026
Q1 		$8.91M Sell
19,956
-305
-2% -$142K 2.75% 6
2025
Q4 		$9.19M Sell
20,261
-100
-0.5% -$43.1K 2.63% 7
2025
Q3 		$7.97M Sell
20,361
-365
-2% -$153K 2.5% 7
2025
Q2 		$9.23M Sell
20,726
-225
-1% -$104K 3.09% 5
2025
Q1 		$10.2M Sell
20,951
-159
-0.8% -$74.1K 3.55% 4
2024
Q4 		$8.5M Sell
21,110
-150
-0.7% -$69.5K 2.95% 6
2024
Q3 		$9.89M Sell
21,260
-206
-1% -$99K 3.38% 6
2024
Q2 		$10.1M Sell
21,466
-350
-2% -$152K 3.61% 6
2024
Q1 		$9.12M Sell
21,816
-475
-2% -$201K 3.4% 6
2023
Q4 		$9.07M Sell
22,291
-265
-1% -$97.9K 3.67% 5
2023
Q3 		$7.84M Sell
22,556
-54
-0.2% -$18.9K 3.49% 5
2023
Q2 		$7.96M Sell
22,610
-60
-0.3% -$20.2K 3.42% 4
2023
Q1 		$7.14M Sell
22,670
-185
-0.8% -$55.5K 3.2% 5
2022
Q4 		$6.6M Sell
22,855
-225
-1% -$68.6K 3.12% 5
2022
Q3 		$6.68M Sell
23,080
-65
-0.3% -$18.7K 3.38% 4
2022
Q2 		$6.52M Sell
23,145
-25
-0.1% -$6.69K 3.13% 5
2022
Q1 		$6.05M Sell
23,170
-910
-4% -$216K 2.49% 7
2021
Q4 		$5.29M Buy
24,080
+400
+2% +$77.8K 2.06% 10
2021
Q3 		$4.29M Buy
23,680
+16,005
+209% +$3.12M 1.94% 11
2021
Q2 		$1.55M Buy
7,675
+150
+2% +$31.4K 0.69% 47
2021
Q1 		$1.62M Buy
+7,525
New +$1.65M 0.79% 45

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AIMZ Investment Advisors's VRTX Position: Q2 2026 in Review

AIMZ Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 0.13% in Q2 2026, selling an estimated $11.1K and leaving 19,931 shares worth $9.9M. The position accounts for 2.72% of the portfolio, ranked #7.

AIMZ Investment Advisors first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $10.2M in Q1 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • AIMZ Investment Advisors held 19,931 shares of Vertex Pharmaceuticals worth $9.9M as of Q2 2026.
  • AIMZ Investment Advisors sold 25 Vertex Pharmaceuticals shares in Q2 2026, an estimated $11.1K.
  • Vertex Pharmaceuticals made up 2.72% of AIMZ Investment Advisors's portfolio in Q2 2026, its #7 holding.
  • AIMZ Investment Advisors first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • AIMZ Investment Advisors's Vertex Pharmaceuticals position peaked at $10.2M in Q1 2025.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.